Beyond safety: rethinking concomitant radiotherapy and trastuzumab deruxtecan in metastatic breast cancer — from feasibility to precision practice

Study limitation reported by the research below: “This is a viewpoint/commentary with no original patient data; findings are opinion-based and reference a single real-world study (Visani et al.) not reproduced here.”